Show simple item record

dc.contributor.authorMohammadian, F
dc.contributor.authorPilehvar-Soltanahmadi, Y
dc.contributor.authorZarghami, F
dc.contributor.authorAkbarzadeh, A
dc.contributor.authorZarghami, N
dc.date.accessioned2018-08-26T07:21:52Z
dc.date.available2018-08-26T07:21:52Z
dc.date.issued2017
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/46184
dc.description.abstractChrysin, as a flavone, has showed cancer chemopreventive activity. The present study utilized the PLGA-PEG-chrysin to evaluate the expression of miR-9 and Let-7a in human gastric cells. The structure of nanoparticles and encapsulated chrysin was evaluated using H-1 NMR, FT-IR, and SEM. MTT assay was used for the evaluation of cytotoxicity effect of nanoencapsulated chrysin. Expression levels of miR-9 and Let7-a were studied by real-time PCR. The results demonstrated that chrysin-PLGA-PEG nanoparticles are more effective than pure chrysin in upregulation of miR-9 and Let-7a due to enhanced uptake by cells. Therefore, PLGA-PEG could be a superior carrier for this kind of hydrophobic agent.
dc.language.isoEnglish
dc.relation.ispartofARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY
dc.subjectPLGA-PEG-chrysin
dc.subjectmiR-9
dc.subjectLet7-a
dc.subjectreal-time PCR
dc.subjectgastric cancer
dc.titleUpregulation of miR-9 and Let-7a by nanoencapsulated chrysin in gastric cancer cells
dc.typeArticle
dc.citation.volume45
dc.citation.issue6
dc.citation.spage1201
dc.citation.epage1206
dc.citation.indexWeb of science
dc.identifier.DOIhttps://doi.org/10.1080/21691401.2016.1216854


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record